Rajasthan Plans End To India Policy Dependence For Open Market
This article was originally published in PharmAsia News
Executive Summary
The head of Rajasthan Drugs and Pharmaceuticals says the company has benefited greatly by India's 2006 policy to cover 102 drugs made by central public-sector undertakings. Managing Director R.K. Vashishtha said Rajasthan's gain also was shared by other COSUs, which were given five years of automatic coverage by the government, public sector enterprises and non-government organizations. For Rajasthan, that has led to a large numbers of orders for its drugs, and the company now seeks to enter the open market with its products, eventually becoming self-reliant. (Click here for more